enVVeno Medical (NVNO) CFO Bright received 350,000 Stock Options
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Jennifer Bright (Chief Financial Officer at enVVeno Medical Corporation, NVNO) reported that they received 350,000 Stock Options on May 19, 2025.
- Reporting person
- Bright Jennifer
- Role
- Chief Financial Officer
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| May 19, 2025 | Grant or award (A) | Stock OptionsOn 350,000 Common Stock1, 2 | +350,000 | - | - | 350,000 direct |
Holdings before and after
- Stock Options: 0 to 350,000 direct
Footnotes from the filing
- 1. The stock option was granted pursuant to the registrant's Amended and Restated 2016 Omnibus Incentive Plan, as amended.
- 2. The stock options shall vest quarterly, over a three (3) year period, with a one (1) year cliff, subject to the reporting person's continued service with the Company.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Bright report in this NVNO Form 4?
Jennifer Bright (Chief Financial Officer at enVVeno Medical Corporation, NVNO) reported that they received 350,000 Stock Options on May 19, 2025.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for NVNO
Earlier insider filings at NVNO
- Jan 3, 2025Director Duhay Francis bought $249,999 worth of shares (81,433 units at $3.07), increasing direct ownership by 389% to 102,344 units (SEC Form 4)
- Jan 2, 2025Director Gray Robert bought $10,290 worth of shares (3,500 units at $2.94), increasing direct ownership by 46% to 11,155 units (SEC Form 4)
- Dec 26, 2024Director Shrivastava Sanjay bought $15,660 worth of shares (5,400 units at $2.90), increasing direct ownership by 139% to 9,288 units (SEC Form 4)
- Dec 23, 2024Director Jenusaitis Matthew bought $24,339 worth of shares (9,620 units at $2.53), increasing direct ownership by 139% to 16,545 units (SEC Form 4)
- Dec 21, 2024SEC Form 4 filed by Chief Technology Officer Alavi Hamed
Quantisnow market dataNASDAQ
NVNO
enVVeno Medical Corporation
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Listed since
- 2018
Get push alerts for NVNO
Full NVNO profile on Quantisnow Follow NVNO and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time